Corporate Overview

Eterna Therapeutics (“Eterna”) is developing transformative new medicines to treat various forms of cancer and other diseases with high unmet medical needs. Eterna’s product pipeline is based on extensively patented foundational mRNA cell engineering technology and offers multiple clinical applications with future sub-licensing and partnering opportunities. Eterna has recruited an experienced leadership team with deep expertise in mRNA cell engineering and cell and gene therapy product development.

Latest Presentation

Latest Events

View All Events